|
Volumn 115, Issue 2, 2002, Pages 227-231
|
In situ transduction of cytosine deaminase gene followed by systemic use of 5-fluorocytosine inhibits tumor growth and metastasis in orthotopic prostate cancer mouse models
|
Author keywords
Animal; Cytosine deaminase; Flucytosine; Gene therapy; Prostatic neoplasms
|
Indexed keywords
ADENOVIRUS VECTOR;
BETA GALACTOSIDASE;
CYTOSINE DEAMINASE;
FLUOROURACIL;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL;
CANCER INHIBITION;
CANCER SURVIVAL;
CONTROLLED STUDY;
GENETIC CODE;
GENETIC TRANSDUCTION;
HISTOPATHOLOGY;
LUNG LYMPH;
LYMPH NODE METASTASIS;
MALE;
METASTASIS;
MOUSE;
NONHUMAN;
PROSTATE CANCER;
VIRAL GENE THERAPY;
ADENOVIRIDAE;
ANIMALS;
CELL DIVISION;
CYTOSINE DEAMINASE;
DISEASE MODELS, ANIMAL;
FLUCYTOSINE;
LYMPHATIC METASTASIS;
MALE;
MICE;
MICE, INBRED C57BL;
NEOPLASM TRANSPLANTATION;
NUCLEOSIDE DEAMINASES;
PROSTATIC NEOPLASMS;
SURVIVAL RATE;
TRANSFECTION;
TUMOR CELLS, CULTURED;
|
EID: 0036198905
PISSN: 03666999
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (18)
|